首页 | 本学科首页   官方微博 | 高级检索  
检索        

中国3岁以上人群乙型肝炎血清流行病学研究
引用本文:梁晓峰,陈园生,王晓军,贺雄,陈丽娟,王骏,林长缨,白呼群,严俊,崔钢,于竞进.中国3岁以上人群乙型肝炎血清流行病学研究[J].中华流行病学杂志,2005,26(9):655-658.
作者姓名:梁晓峰  陈园生  王晓军  贺雄  陈丽娟  王骏  林长缨  白呼群  严俊  崔钢  于竞进
作者单位:1. 100050,北京,中国疾病预防控制中心
2. 北京市疾病预防控制中心
3. 卫生部疾病控制司
基金项目:中国药品生物制品检定所为本次乙肝血清学检测免费提供试剂质控品;实验室检测得到中国工程院院士、北京大学医学部庄辉教授和中国肝炎基金会诸多专家的支持与指导;并得到中国疾病预防控制中心病毒病预防控制所、营养与食品安全所和公共卫生监测与信息中心诸多专家与领导的支持,一并致谢
摘    要:目的了解中国现阶段乙型肝炎(乙肝)病毒(HBV)感染现状和评价自1992年乙肝疫苗纳人儿童免疫策略所取得效果。方法利用中国疾病预防控制中心“2002年中国居民营养与健康状况调查”保留的血清开展乙肝血清学检测。以美国Abbott乙肝酶联免疫吸附试验(ELISA)试剂为金标准选择中国乙肝ELISA检测试剂,并用固相放射免疫方法校对检测结果。结果中国≥3岁人群HBsAg阳性率、抗-HBs阳性率、HBV流行率经调整后分别为9.09%、37.48%、50.04%;3~12岁儿童分别为5.03%、45.33%、29.10%。≥3岁城市人群HBsAg阳性率、HBV流行率分别为4.61%、43.51%,农村人群分别为9.41%、56.77%。3~12岁城市儿童HBsAg阳性率、HBV流行率分别为2.10%、20.45%,农村儿童分别为8.25%、39.22%。结论中国≥3岁人群乙肝流行病学特征已发生改变,乙肝疫苗纳人儿童免疫规划效果显著,人群HBsAg阳性率、HBV流行率均有不同程度下降,3~12岁儿童下降更为明显。

关 键 词:乙型肝炎  血清流行病学  乙型肝炎疫苗  免疫接种  中国疾病预防控制中心  血清流行病学研究  城市人群  酶联免疫吸附试验(ELISA)  HBsAg阳性率  抗-HBs阳性率
收稿时间:03 9 2005 12:00AM
修稿时间:2005年3月9日

A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old
LIANG Xiao-feng,CHEN Yuan-sheng,WANG Xiao-jun,HE Xiong,CHEN Li-juan,WANG Jun,LIN Chang-ying,BAI Hu-qun,YAN Jun,CUI Gang and YU Jing-jin.A study on the sero-epidemiology of hepatitis B in Chinese population aged over 3-years old[J].Chinese Journal of Epidemiology,2005,26(9):655-658.
Authors:LIANG Xiao-feng  CHEN Yuan-sheng  WANG Xiao-jun  HE Xiong  CHEN Li-juan  WANG Jun  LIN Chang-ying  BAI Hu-qun  YAN Jun  CUI Gang and YU Jing-jin
Institution:Chinese Center for Disease Control and Prevention, Beijing 100050, China.
Abstract:Objective To better understand and measure the impact from immunization activities over the last 10-years, we conducted a sero-epidemiological study using the remaining blood samples of a nationwide survey on Nutrition and Health in Chinese residents, in 2002. Methods HBsAg, anti-HBs and anti-HBc in blood samples were tested using enzyme-linked immunosorbent assay(ELISA) reagents and revised by solid phase radioimmunoassay and Abbott ELISA reagents. Results Among population older than 3 years, the prevalence rates of HBsAg, anti-HBs and hepatitis B virus(HBV) infection were 9.09% , 37.48% and 50.04% but for children between 3 and 12 year olds, they were 5.03%, 45.33% and 29.10% respectively. Among population older than 3 years, the rates of HBsAg and HBV infection in urban area were4.61% and 43.51% , but the rates in rural area were 9.41% and 56.77% respectively while for children from 3-years to 12-years old, they rates were 2.10%, 20.45% in urban area and 8.25%, 39.22% in rural areas, respectively. Conclusion Results revealed that since the hepatitis B vaccine was introduced into the expanded program on immunization(EPI) from 1992, the prevalence rates of HBsAg and HBV infection, especially in the children from 3 to 12 years of age, had obviously declined, suggesting that some changes had happened in the epidemic characters of hepatitis B in China.
Keywords:Hepatitis B  Sero-epidemiology  Hepatitis B vaccine  Vaccinate
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中华流行病学杂志》浏览原始摘要信息
点击此处可从《中华流行病学杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号